Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Net Income (2020 - 2024)

Roivant Sciences (ROIV) has disclosed Net Income for 5 consecutive years, with $327.0 million as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Net Income rose 658.87% year-over-year to $327.0 million, compared with a TTM value of $327.0 million through Sep 2025, up 200.02%, and an annual FY2025 reading of $373.2 million, changed N/A over the prior year.
  • Net Income was $327.0 million for Q4 2024 at Roivant Sciences, up from -$236.8 million in the prior quarter.
  • Across five years, Net Income topped out at $327.0 million in Q4 2024 and bottomed at -$684.4 million in Q3 2021.
  • Average Net Income over 5 years is -$175.4 million, with a median of -$101.1 million recorded in 2021.
  • The sharpest move saw Net Income plummeted 3332.99% in 2021, then surged 658.87% in 2024.
  • Year by year, Net Income stood at -$8.9 million in 2020, then tumbled by 3332.99% to -$306.1 million in 2021, then dropped by 25.75% to -$384.9 million in 2022, then skyrocketed by 84.8% to -$58.5 million in 2023, then soared by 658.87% to $327.0 million in 2024.
  • Business Quant data shows Net Income for ROIV at $327.0 million in Q4 2024, -$236.8 million in Q3 2024, and -$31.6 million in Q2 2024.